HIF1A and obstructive sleep apnea syndrome: In the present work, we found a significant decrease of HIF‐1α mRNA in the plasma of severe OSAHS patients who had been treated with CPAP, the gold standard therapy that delivers pressurized air into the upper airway to relieve obstruction during sleep,30 indicating that HIF‐1α mRNA may serve as an indicator for the therapeutic efficacy.